Monoclonal gammopathy of undetermined significance

Robert A. Kyle, S Vincent Rajkumar

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The term monoclonal gammopathy of undetermined significance (MGUS) denotes the presence of a monoclonal protein (M protein) in persons without evidence of multiple myeloma (MM), Waldenström's macroglobulinemia (WM), AL amyloidosis (AL), or other related diseases. MGUS is characterized by a serum M-protein concentration of less than 3.0 g/dL; less than 10 % clonal plasma cells in the bone marrow; and the absence of end-organ damage (CRAB-hypercalcemia, renal insufficiency, anemia, and bone lesions) related to the plasma cell proliferative disorder [1-4].

Original languageEnglish (US)
Title of host publicationNeoplastic Diseases of the Blood
PublisherSpringer New York
Pages751-785
Number of pages35
ISBN (Print)9781461437642, 1461437636, 9781461437635
DOIs
StatePublished - Nov 1 2013

Fingerprint

Monoclonal Gammopathy of Undetermined Significance
Amyloidosis
Plasma Cells
Waldenstrom Macroglobulinemia
Hypercalcemia
Multiple Myeloma
Renal Insufficiency
Anemia
Blood Proteins
Bone Marrow
Bone and Bones
Proteins

Keywords

  • Long-term outcome of MGUS
  • MGUS association with other diseases
  • MGUS prevalence
  • Risk factors for progression of MGUS
  • Variants of MGUS

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kyle, R. A., & Rajkumar, S. V. (2013). Monoclonal gammopathy of undetermined significance. In Neoplastic Diseases of the Blood (pp. 751-785). Springer New York. https://doi.org/10.1007/978-1-4614-3764-2_38

Monoclonal gammopathy of undetermined significance. / Kyle, Robert A.; Rajkumar, S Vincent.

Neoplastic Diseases of the Blood. Springer New York, 2013. p. 751-785.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kyle, RA & Rajkumar, SV 2013, Monoclonal gammopathy of undetermined significance. in Neoplastic Diseases of the Blood. Springer New York, pp. 751-785. https://doi.org/10.1007/978-1-4614-3764-2_38
Kyle RA, Rajkumar SV. Monoclonal gammopathy of undetermined significance. In Neoplastic Diseases of the Blood. Springer New York. 2013. p. 751-785 https://doi.org/10.1007/978-1-4614-3764-2_38
Kyle, Robert A. ; Rajkumar, S Vincent. / Monoclonal gammopathy of undetermined significance. Neoplastic Diseases of the Blood. Springer New York, 2013. pp. 751-785
@inbook{1f08dd231eca4528989fa1cdc6d2648a,
title = "Monoclonal gammopathy of undetermined significance",
abstract = "The term monoclonal gammopathy of undetermined significance (MGUS) denotes the presence of a monoclonal protein (M protein) in persons without evidence of multiple myeloma (MM), Waldenstr{\"o}m's macroglobulinemia (WM), AL amyloidosis (AL), or other related diseases. MGUS is characterized by a serum M-protein concentration of less than 3.0 g/dL; less than 10 {\%} clonal plasma cells in the bone marrow; and the absence of end-organ damage (CRAB-hypercalcemia, renal insufficiency, anemia, and bone lesions) related to the plasma cell proliferative disorder [1-4].",
keywords = "Long-term outcome of MGUS, MGUS association with other diseases, MGUS prevalence, Risk factors for progression of MGUS, Variants of MGUS",
author = "Kyle, {Robert A.} and Rajkumar, {S Vincent}",
year = "2013",
month = "11",
day = "1",
doi = "10.1007/978-1-4614-3764-2_38",
language = "English (US)",
isbn = "9781461437642",
pages = "751--785",
booktitle = "Neoplastic Diseases of the Blood",
publisher = "Springer New York",

}

TY - CHAP

T1 - Monoclonal gammopathy of undetermined significance

AU - Kyle, Robert A.

AU - Rajkumar, S Vincent

PY - 2013/11/1

Y1 - 2013/11/1

N2 - The term monoclonal gammopathy of undetermined significance (MGUS) denotes the presence of a monoclonal protein (M protein) in persons without evidence of multiple myeloma (MM), Waldenström's macroglobulinemia (WM), AL amyloidosis (AL), or other related diseases. MGUS is characterized by a serum M-protein concentration of less than 3.0 g/dL; less than 10 % clonal plasma cells in the bone marrow; and the absence of end-organ damage (CRAB-hypercalcemia, renal insufficiency, anemia, and bone lesions) related to the plasma cell proliferative disorder [1-4].

AB - The term monoclonal gammopathy of undetermined significance (MGUS) denotes the presence of a monoclonal protein (M protein) in persons without evidence of multiple myeloma (MM), Waldenström's macroglobulinemia (WM), AL amyloidosis (AL), or other related diseases. MGUS is characterized by a serum M-protein concentration of less than 3.0 g/dL; less than 10 % clonal plasma cells in the bone marrow; and the absence of end-organ damage (CRAB-hypercalcemia, renal insufficiency, anemia, and bone lesions) related to the plasma cell proliferative disorder [1-4].

KW - Long-term outcome of MGUS

KW - MGUS association with other diseases

KW - MGUS prevalence

KW - Risk factors for progression of MGUS

KW - Variants of MGUS

UR - http://www.scopus.com/inward/record.url?scp=84929559128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929559128&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-3764-2_38

DO - 10.1007/978-1-4614-3764-2_38

M3 - Chapter

AN - SCOPUS:84929559128

SN - 9781461437642

SN - 1461437636

SN - 9781461437635

SP - 751

EP - 785

BT - Neoplastic Diseases of the Blood

PB - Springer New York

ER -